Top Markets
Coin of the day
Theraclion SA Theraclion SA

Theraclion SA

ALTHE
Rangering i aksjer #15409
Theraclion SA develops echotherapy solutions using high intensity focused... Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Aksjekurs
$0.78404857
Markedsverdi
$36.98M
Endring (1 dag)
-1.49%
Endring (1 år)
139.26%
Land
FR
Handel Theraclion SA (ALTHE)

Kategori

P/B-forhold for Theraclion SA (ALTHE)
P/B-forhold per July 2026 TTM: -14.11
Ifølge Theraclion SA sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) -14.11. Ved slutten av 2023 hadde selskapet et P/B-forhold på 3.14.
P/B-historikk for Theraclion SA fra 2010 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) -14.11 -99.99%
2024 -133.83K -4,259,251.68%
2023 3.14 -93.56%
2022 48.76 -308.04%
2021 -23.44 132.26%
2020 -10.09 -96.80%
2019 -315.54 2,868.09%
2018 -10.63 -221.88%
2017 8.72 44.54%
2016 6.03 -82.25%
2015 34.00 228.35%
2014 10.36 -210.01%
2013 -9.41 -107.46%
2012 126.12 -59.55%
2011 311.80 959.96%
2010 29.42 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
3.0429 -121.56%
US
5.2455 -137.17%
US
2.0273 -114.37%
IE
2.4503 -117.36%
US
5.0733 -135.95%
US